Clinical Trials Directory

Trials / Completed

CompletedNCT00256165

REST Study: Left Ventricular Regression European Study

Left Ventricular Regression European Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Abbott Medical Devices · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to obtain data regarding the left ventricular mass (LVM) regression 6 months after the implant of an SJM Epic™ and SJM Epic™ Supra valve by comparing LVM regression measured with magnetic resonance imaging (MRI) to LVM regression measured with echocardiography (2-dimensional \[2D\] mandatory; 3-dimensional \[3D\] in sites where the technology is available).

Conditions

Interventions

TypeNameDescription
DEVICETissue valveAortic valve replacement

Timeline

Start date
2006-01-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2005-11-21
Last updated
2019-02-04

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00256165. Inclusion in this directory is not an endorsement.